2020
DOI: 10.5430/jst.v10n2p7
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic significance of annexin II , human epididymis protein (HE-4) and claudin in endometrial carcinoma

Abstract: Introduction: Endometrial cancer (EC) is one of the most prevalent malignant tumors of the female reproductive system worldwide. Annexins are membrane binding proteins with important role in tumor development and progression. Human Epididymis Protein (HE-4) is a novel marker for gynecolgical tumors. Claudins are proteins of tight junction category playing an important role in cell adhesion and tumor spread.Material and methods: Seventy blocks of paraffin-embedded tissues of endometrial carcinoma cases. Immunoh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 31 publications
0
1
0
Order By: Relevance
“…The flow chart of literature screening is shown in Figure 1. among these studies, eight were from China, [7][8][9][10][11][12][13][14] four from Italy, [15][16][17][18] four from Poland, [19][20][21][22] three from Iran, [23][24][25] two from Australia, 26,27 two from Czech Republic, 28,29 two from Egypt, 30,31 two from Thailand, 32,33 two from The Netherlands, 34,35 two from Turkey, 36,37 and one each was from America, Austria, Denmark, India, Ireland, Slovenia, and Spain. [38][39][40][41][42][43][44] Thirty-three studies described the relationship between serum HE4 levels and the clinicopathological characteristics of EC, three studies described the relationship between tissue HE4 expression and the clinicopathological characteristics of EC, and two studies examined HE4 expression in both samples.…”
Section: Study Selection and Characteristicsmentioning
confidence: 99%
“…The flow chart of literature screening is shown in Figure 1. among these studies, eight were from China, [7][8][9][10][11][12][13][14] four from Italy, [15][16][17][18] four from Poland, [19][20][21][22] three from Iran, [23][24][25] two from Australia, 26,27 two from Czech Republic, 28,29 two from Egypt, 30,31 two from Thailand, 32,33 two from The Netherlands, 34,35 two from Turkey, 36,37 and one each was from America, Austria, Denmark, India, Ireland, Slovenia, and Spain. [38][39][40][41][42][43][44] Thirty-three studies described the relationship between serum HE4 levels and the clinicopathological characteristics of EC, three studies described the relationship between tissue HE4 expression and the clinicopathological characteristics of EC, and two studies examined HE4 expression in both samples.…”
Section: Study Selection and Characteristicsmentioning
confidence: 99%